These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9103341)

  • 1. Syringe and needle regulation, blood-borne disease transmission, and concern for public safety.
    Friedland G
    JAMA; 1997 Apr; 277(15):1202-3; author reply 1203. PubMed ID: 9103341
    [No Abstract]   [Full Text] [Related]  

  • 2. Syringe and needle regulation, blood-borne disease transmission, and concern for public safety.
    Tsao K; Roaf EA
    JAMA; 1997 Apr; 277(15):1203; author reply 1203. PubMed ID: 9103342
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles.
    Gostin LO; Lazzarini Z; Jones TS; Flaherty K
    JAMA; 1997 Jan; 277(1):53-62. PubMed ID: 8980211
    [No Abstract]   [Full Text] [Related]  

  • 4. The genesis of syringe prescription to prevent HIV in Rhode Island.
    Rich JD; McKenzie M; Macalino G; Runnarsdottir V; Gaydos M; Mehrotra M; Stein J; Whitlock T; Salas C; Burris S
    Health Matrix Clevel; 2001; 11(1):129-45. PubMed ID: 11345673
    [No Abstract]   [Full Text] [Related]  

  • 5. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.
    Gostin LO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S60-70. PubMed ID: 9663626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of syringes and needles for medical use and to prevent the spread of blood-borne pathogens among illicit injection drug users.
    Morse LJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S143-4. PubMed ID: 9663640
    [No Abstract]   [Full Text] [Related]  

  • 8. Syringe access for the prevention of blood borne infections among injection drug users.
    Stancliff S; Agins B; Rich JD; Burris S
    BMC Public Health; 2003 Nov; 3():37. PubMed ID: 14633286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users.
    Burris S; Lurie P; Ng M
    Health Matrix Clevel; 2001; 11(1):5-64. PubMed ID: 11345676
    [No Abstract]   [Full Text] [Related]  

  • 10. An analysis of ethical issues in prescribing and dispensing syringes to injection drug users.
    Lazzarini Z
    Health Matrix Clevel; 2001; 11(1):85-128. PubMed ID: 11345679
    [No Abstract]   [Full Text] [Related]  

  • 11. Following the blood: syringe reuse leads to blood-borne virus transmission among injection drug users.
    Koester S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S139-40. PubMed ID: 9663637
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of numbers in ethical analysis.
    Nilstun T; Westrin CG
    Health Care Anal; 1994 Feb; 2(1):43-6. PubMed ID: 10134371
    [No Abstract]   [Full Text] [Related]  

  • 13. Should pharmacists sell sterile syringes to injection drug users?
    Jones TS; Taussig J
    J Am Pharm Assoc (Wash); 1999; 39(1):8-10. PubMed ID: 9990178
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug use and harm reduction policy: alternative perspectives on the California proposal.
    Stauffer L
    J Health Soc Policy; 2004; 19(3):19-36. PubMed ID: 15829451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringe type and drug injector risk for HIV infection: a case study in Texas.
    Zule WA; Desmond DP; Neff JA
    Soc Sci Med; 2002 Oct; 55(7):1103-13. PubMed ID: 12365524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction treatment: promoting a medical approach to substance use.
    Stein GL; Fleischman AR
    J Urban Health; 1998 Sep; 75(3):558-83. PubMed ID: 9762650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringe cleaning techniques and transmission of HIV.
    Druce JD; Locarnini SA; Birch CJ
    AIDS; 1995 Sep; 9(9):1105-7. PubMed ID: 8527090
    [No Abstract]   [Full Text] [Related]  

  • 19. Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs.
    Gaughwin MD; Gowans E; Ali R; Burrell C
    AIDS; 1991 Aug; 5(8):1025-7. PubMed ID: 1777162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols.
    McCoy CB; Shapshak P; Metsch LR; Rivers JE; McCoy HV; Weatherby NL; Shah SM; Chitwood DD
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):1-9. PubMed ID: 8744677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.